Search results
Results from the WOW.Com Content Network
Because liver cancer is an umbrella term for many types of cancer, the signs and symptoms depend on what type of cancer is present. Symptoms can be vague and broad. Symptoms can be vague and broad. Cholangiocarcinoma is associated with sweating , jaundice , abdominal pain , weight loss , and liver enlargement . [ 11 ]
Cholangiocarcinoma, also known as bile duct cancer, is a type of cancer that forms in the bile ducts. [2] Symptoms of cholangiocarcinoma may include abdominal pain, yellowish skin, weight loss, generalized itching, and fever. [1] Light colored stool or dark urine may also occur. [4]
Liver function tests (LFTs or LFs), also referred to as a hepatic panel or liver panel, are groups of blood tests that provide information about the state of a patient's liver. [1] These tests include prothrombin time (PT/INR), activated partial thromboplastin time (aPTT), albumin , bilirubin (direct and indirect), and others.
MASLD constitutes the third most common risk factor for liver cancer. [130] Cirrhosis is found in only about 50% of people with MASLD and with liver cancer, so liver cancer may occur without cirrhosis being present. [14] MASLD is a precursor of metabolic syndrome, although a bidirectional influence is possible.
Blood tests and medical imaging are used to diagnose NAFLD and NASH, and sometimes a liver biopsy is needed. [39] Chronic hepatitis C, an infection with the hepatitis C virus, causes inflammation of the liver and a variable grade of damage to the organ. [44] Over several decades, this inflammation and damage can lead to cirrhosis.
Blood tests should be done, especially liver-function tests, which give a good impression of the patient's broad metabolic picture. [medical citation needed]A complete blood test can help distinguish intrinsic liver disease from extrahepatic bile-duct obstruction. [19]
Hepatocellular carcinoma (HCC [1]) is the most common type of primary liver cancer in adults and is currently the most common cause of death in people with cirrhosis. [2] HCC is the third leading cause of cancer-related deaths worldwide.
FibroTest, known as FibroSure in the US, is a biomarker test that uses the results of six blood serum tests to generate a score that is correlated with the degree of liver damage in people with a variety of liver diseases. FibroTest has the same prognostic value as a liver biopsy.